Cargando…

FOXO1 controls protein synthesis and transcript abundance of mutant polyglutamine proteins, preventing protein aggregation

FOXO1, a transcription factor downstream of the insulin/insulin like growth factor axis, has been linked to protein degradation. Elevated expression of FOXO orthologs can also prevent the aggregation of cytosine adenine guanine (CAG)-repeat disease causing polyglutamine (polyQ) proteins but whether...

Descripción completa

Detalles Bibliográficos
Autores principales:	Furtado, Gabriel Vasata, Yang, Jing, Wu, Di, Papagiannopoulos, Christos I, Terpstra, Hanna M, Kuiper, E F Elsiena, Krauss, Sybille, Zhu, Wei-Guo, Kampinga, Harm H, Bergink, Steven
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	General Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170844/ https://www.ncbi.nlm.nih.gov/pubmed/33822053 http://dx.doi.org/10.1093/hmg/ddab095

Ejemplares similares

Chaperones in Polyglutamine Aggregation: Beyond the Q-Stretch
por: Kuiper, E. F. E., et al.
Publicado: (2017)

Versatile members of the DNAJ family show Hsp70 dependent anti-aggregation activity on RING1 mutant parkin C289G
por: Kakkar, Vaishali, et al.
Publicado: (2016)

Myopathy associated BAG3 mutations lead to protein aggregation by stalling Hsp70 networks
por: Meister-Broekema, Melanie, et al.
Publicado: (2018)

Ubiquitin conjugating enzymes participate in polyglutamine protein aggregation
por: Howard, Rebecca A, et al.
Publicado: (2007)

Rescue of αB Crystallin (HSPB5) Mutants Associated Protein Aggregation by Co-Expression of HSPB5 Partners
por: Hussein, Rasha M., et al.
Publicado: (2015)

Nuclear polyglutamine-containing protein aggregates as active proteolytic centers
por: Chen, Min, et al.
Publicado: (2008)

Proteins with Intrinsically Disordered Domains Are Preferentially Recruited to Polyglutamine Aggregates
por: Wear, Maggie P., et al.
Publicado: (2015)

Protein Misfolding and Aggregation as a Therapeutic Target for Polyglutamine Diseases
por: Takeuchi, Toshihide, et al.
Publicado: (2017)

Protein Aggregation Inhibitors as Disease-Modifying Therapies for Polyglutamine Diseases
por: Minakawa, Eiko N., et al.
Publicado: (2021)

DNAJB6b-enriched small extracellular vesicles decrease polyglutamine aggregation in in vitro and in vivo models of Huntington disease
por: Joshi, Bhagyashree S., et al.
Publicado: (2021)

Identities of Sequestered Proteins in Aggregates from Cells with Induced Polyglutamine Expression
por: Suhr, Steven T., et al.
Publicado: (2001)

Modifiers of mutant huntingtin aggregation: functional conservation of C. elegans-modifiers of polyglutamine aggregation
por: Teuling, Eva, et al.
Publicado: (2011)

Conformational Targeting of Fibrillar Polyglutamine Proteins in Live Cells Escalates Aggregation and Cytotoxicity
por: Kvam, Erik, et al.
Publicado: (2009)

Stress granules, RNA-binding proteins and polyglutamine diseases: too much aggregation?
por: Marcelo, Adriana, et al.
Publicado: (2021)

Protein Quality Control Pathways at the Crossroad of Synucleinopathies
por: De Mattos, Eduardo P., et al.
Publicado: (2020)

Nucleation of protein aggregation kinetics as a basis for genotype-phenotype correlations in polyglutamine diseases
por: Sugaya, Keizo, et al.
Publicado: (2009)

Ubiquitination is involved in secondary growth, not initial formation of polyglutamine protein aggregates in C. elegans
por: Skibinski, Gregory A, et al.
Publicado: (2012)

The Ginkgo biloba Extract EGb 761 Modulates Proteasome Activity and Polyglutamine Protein Aggregation
por: Stark, Marcel, et al.
Publicado: (2014)

A discontinuous Galerkin model for fluorescence loss in photobleaching of intracellular polyglutamine protein aggregates
por: Hansen, Christian V., et al.
Publicado: (2018)

PML clastosomes prevent nuclear accumulation of mutant ataxin-7 and other polyglutamine proteins
por: Janer, Alexandre, et al.
Publicado: (2006)

Association of polyalanine and polyglutamine coiled coils mediates expansion disease-related protein aggregation and dysfunction
por: Pelassa, Ilaria, et al.
Publicado: (2014)

CAG Expansions Are Genetically Stable and Form Nontoxic Aggregates in Cells Lacking Endogenous Polyglutamine Proteins
por: Zurawel, Ashley A., et al.
Publicado: (2016)

Nuclear accumulation of polyglutamine disease proteins and neuropathology
por: Havel, Lauren S, et al.
Publicado: (2009)

Praja1 ubiquitin ligase facilitates degradation of polyglutamine proteins and suppresses polyglutamine-mediated toxicity
por: Ghosh, Baijayanti, et al.
Publicado: (2021)

Evolution and function of CAG/polyglutamine repeats in protein–protein interaction networks
por: Schaefer, Martin H., et al.
Publicado: (2012)

DNAJs: more than substrate delivery to HSPA
por: Dekker, Suzanne L., et al.
Publicado: (2015)

Molecular Origin of Polyglutamine Aggregation in Neurodegenerative Diseases
por: Khare, Sagar D, et al.
Publicado: (2005)

Candida albicans Is Resistant to Polyglutamine Aggregation and Toxicity
por: Leach, Michelle D., et al.
Publicado: (2016)

Formation and persistence of polyglutamine aggregates in mistranslating cells
por: Lant, Jeremy T, et al.
Publicado: (2021)

Structure prediction of polyglutamine disease proteins: comparison of methods
por: Wen, Jingran, et al.
Publicado: (2014)

Quantification Assays for Total and Polyglutamine-Expanded Huntingtin Proteins
por: Macdonald, Douglas, et al.
Publicado: (2014)

Huntingtin toxicity in yeast model depends on polyglutamine aggregation mediated by a prion-like protein Rnq1
por: Meriin, Anatoli B., et al.
Publicado: (2002)

Splice Isoforms of the Polyglutamine Disease Protein Ataxin-3 Exhibit Similar Enzymatic yet Different Aggregation Properties
por: Harris, Ginny Marie, et al.
Publicado: (2010)

Natural Genetic Variation in Yeast Reveals That NEDD4 Is a Conserved Modifier of Mutant Polyglutamine Aggregation
por: Peters, Theodore W., et al.
Publicado: (2018)

Polyglutamine Expansion Mutation Yields a Pathological Epitope Linked to Nucleation of Protein Aggregate: Determinant of Huntington's Disease Onset
por: Sugaya, Keizo, et al.
Publicado: (2007)

DNAJB6 is a peptide-binding chaperone which can suppress amyloid fibrillation of polyglutamine peptides at substoichiometric molar ratios
por: Månsson, Cecilia, et al.
Publicado: (2013)

Recruitment and the Role of Nuclear Localization in Polyglutamine-mediated Aggregation
por: Perez, Matthew K., et al.
Publicado: (1998)

Cell-to-cell Transmission of Polyglutamine Aggregates in C. elegans
por: Kim, Dong-Kyu, et al.
Publicado: (2017)

Molecular dynamics analysis of the aggregation propensity of polyglutamine segments
por: Wen, Jingran, et al.
Publicado: (2017)

Misfolding of Proteins with a Polyglutamine Expansion Is Facilitated by Proteasomal Chaperones
por: Rousseau, Erwann, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_n8cvtkoabtn1k5nrcuvtd899ru